Walleye Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Walleye Trading’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-63,200	Closed	-$1.14M	–	4945
2020 Q2	$1.14M	Buy	63,200 +39,700	+169%	+$552K	0.01%	1550
2020 Q1	$168K	Sell	23,500 -13,900	-37%	-$173K	﹤0.01%	2758
2019 Q4	$893K	Buy	37,400 +33,000	+750%	+$910K	0.01%	1897
2019 Q3	$118K	Buy	4,400 +2,600	+144%	+$73K	﹤0.01%	3260
2019 Q2	$49K	Sell	1,800 -16,100	-90%	-$505K	﹤0.01%	3552
2019 Q1	$621K	Sell	17,900 -87,200	-83%	-$2.52M	﹤0.01%	2072
2018 Q4	$2.05M	Buy	105,100 +65,900	+168%	+$1.36M	0.02%	1055
2018 Q3	$1.04M	Buy	39,200 +30,400	+345%	+$993K	0.01%	2019
2018 Q2	$332K	Buy	+8,800	New	+$337K	﹤0.01%	3213

Walleye Trading's PTLA Position: Q3 2020 in Review

Walleye Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 18,001 shares — an estimated $324K sold.

Walleye Trading first reported a position in PTLA in Q2 2015 and held it in 12 quarters. The position peaked at $574K in Q4 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Walleye Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Walleye Trading sold 18,001 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $324K.
Walleye Trading first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 12 quarters.
Walleye Trading's Portola Pharmaceuticals, Inc. position peaked at $574K in Q4 2018.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.